# Roivant Sciences Ltd (ROIV) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2026 | -$515M |
| 2025 | -$1.00B |
| 2024 | $4.50B |
| 2023 | -$907M |
| 2022 | -$1.35B |
| 2021 | -$1.07B |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-12-31 | -$339M |
| 2025-09-30 | -$306M |
| 2025-06-30 | -$285M |
| 2024-12-31 | -$274M |
| 2024-09-30 | -$342M |
| 2024-06-30 | -$102M |
| 2023-12-31 | $5.13B |
| 2023-09-30 | -$214M |
| 2023-06-30 | -$276M |
| 2022-12-31 | -$378M |
| 2022-09-30 | -$281M |
| 2022-06-30 | -$282M |
| 2021-12-31 | -$246M |
| 2021-09-30 | -$684M |
| 2021-06-30 | -$154M |
| 2020-12-31 | -$259M |
| 2020-09-30 | -$157M |
| 2020-06-30 | -$114M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ROIV/operating-income)